Beibei Yang

Papers

Total Citations

H-Index

About

Beibei Yang is a pioneering researcher in advanced drug delivery systems, with a primary focus on microneedle technology for overcoming biological barriers. Her most-cited work, "Microneedle Technology for Overcoming Biological Barriers: Advancing Biomacromolecular Delivery and Therapeutic Applications in Major Diseases" (2025), has already garnered 5 citations, highlighting its immediate impact. Yang’s major contribution lies in systematically addressing the critical challenge of administering biomacromolecules—such as proteins, peptides, and nucleic acids—which are revolutionizing therapies for tumors, infections, cardiovascular diseases, metabolic disorders, and autoimmune conditions. By demonstrating how microneedles can bypass traditional biological barriers, her research enables non-invasive, patient-friendly delivery of these fragile therapeutics, reducing dependence on professional administration. This work not only advances fundamental understanding of transdermal and mucosal delivery but also opens new avenues for treating major diseases with improved efficacy and accessibility. Yang’s innovative approach positions her at the forefront of translational biomedicine, bridging the gap between laboratory breakthroughs and clinical applications. Her findings are essential reading for students and researchers seeking to understand how microneedle platforms can transform the future of precision medicine.